A Single Centre Observational Study to Assess whether a Topically Applied Cannabidiol Gel can Reduce Pain, Increase Grip Strength, or Improve Joint Functionality for Sufferers of Painful Osteoarthritis of the Hand

Avecho Biotechnology0 个研究点目标入组 15 人开始时间: 2021年11月5日最近更新: 2022年5月23日

适应症

试验速览

暂无简介。

•Males and females with symptomatic hand OA affecting the fingers and thumb.
•- At least 3 joints affected by distal interphalangeal (DIP) nodal hand OA, defined by Heberden's Nodes on physical exam.
•- At least one DIP nodal hand OA with:
•-Sufficiently severe frequent pain, as categorized by a minimum NPRS pain severity of 3 on a 0 - 10 scale.
•-Frequent pain: pain on most days of the month for at least one month in the last year.
•- Access to the internet and a smart phone, and the ability to use an app.
•- Able to understand and sign the Informed Consent Form.
•- Willing to follow the protocol requirements and comply with protocol restrictions.

•- History or current inflammatory arthritis (examples: gout, psoriatic arthritis, and rheumatoid arthritis).
•- Medications and/or medical conditions that are likely to change over the 6-week trial period.
•- Prior surgery on the DIP joints.
•- Pregnancy or lactation.
•- Dermatology conditions of the hand.
•- Regular self-reported use of cannabis, or cannabis-based products during the past three months.
•- Known allergies or hypersensitivity to cannabis-based products or any of the excipients in the study drug.

发起方

Avecho Biotechnology